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Abstract
Background: Stakeholder engagement is being increasingly recognised as an important way to achieving impact in
public health. The WorkHORSE (Working Health Outcomes Research Simulation Environment) project was designed to
continuously engage with stakeholders to inform the development of an open access modelling tool to enable
commissioners to quantify the potential cost-effectiveness and equity of the NHS Health Check Programme.
An objective of the project was to evaluate the involvement of stakeholders in co-producing the WorkHORSE
computer modelling tool and examine how they perceived their involvement in the model building process and
ultimately contributed to the strengthening and relevance of the modelling tool.
Methods: We identified stakeholders using our extensive networks and snowballing techniques. Iterative development
of the decision support modelling tool was informed through engaging with stakeholders during four workshops. We
used detailed scripts facilitating open discussion and opportunities for stakeholders to provide additional feedback
subsequently. At the end of each workshop, stakeholders and the research team completed questionnaires to explore
their views and experiences throughout the process.
Results: 30 stakeholders participated, of which 15 attended two or more workshops. They spanned local (NHS
commissioners, GPs, local authorities and academics), third sector and national organisations including Public Health England.
Stakeholders felt valued, and commended the involvement of practitioners in the iterative process. Major reasons for
attending included: being able to influence development, and having insight and understanding of what the tool could
include, and how it would work in practice. Researchers saw the process as an opportunity for developing a common
language and trust in the end product, and ensuring the support tool was transparent. The workshops acted as a reality
check ensuring model scenarios and outputs were relevant and fit for purpose.
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Conclusions: Computational modellers rarely consult with end users when developing tools to inform decision-making. The
added value of co-production (continuing collaboration and iteration with stakeholders) enabled modellers to produce a
“real-world” operational tool. Likewise, stakeholders had increased confidence in the decision support tool’s development and
applicability in practice.
Keywords: Co-production, Stakeholder engagement, Group model building, NHS health checks
Background
Assessing which interventions are most effective, cost-
effective and equitable are difficult in public health due to
its existence in a complex dynamic system. Dynamic
simulation models are increasingly used within the health
sector, including public health to optimise decisions in
limited resource settings [1]. Therefore, they can be used
to model potential interventions and their outcomes to
help inform decision-making. However, uptake of ‘return
on investment’ type tools by decision-makers is low.
Whilst stakeholder engagement in conceptual model
building is well established [2, 3], and studies to explore
why stakeholders do not use simulation models [4–6]
exist, studies describing active engagement with stake-
holders during computational model building are lacking.
Research Councils are increasingly encouraging re-
searchers to consider the wider impact of their research.
As part of a strategy to ensure research is of benefit and
relevance in the “real world” beyond academia and has the
greatest impact to the end-user, stakeholder engagement
is a key component in public health research [7, 8].
The concept of stakeholder theory was originally de-
scribed by Freeman (1984) [9]. Freeman described the role
of stakeholder theory in relation to organisational business
management and stressed the interrelated relationships
between a business and its customers, suppliers, em-
ployees, investors, communities and others who have a
stake in the organization. Stakeholder engagement has
been adapted, applied and increasingly used in the field of
health research. Boaz (2018) [10] identifies three key prin-
ciples for stakeholder engagement in health research: 1.
Organisational (e.g. clear objectives, resources, inclusion
of key stakeholders); 2. Values (e.g. commitment of project
team, shared understanding and commitment); 3. Prac-
tices (e.g. flexibilty within the research process, systematic
data gathering, involvement of stakeholders as an iterative
process). In the context of the WorkHORSE (Working
Health Outcomes Research Simulation Environment) pro-
ject, we defined and identified stakeholders as individuals
and organisations who would be the commissioners and
users of the WorkHORSE modelling tool to make deci-
sions regarding increasing the uptake of the NHS Health
Check Programme based upon effectiveness, cost-
effectiveness and equity). However, we also acknowledge
that there will be a wider group of beneficiaries of the
modelling tool including the computer modelling commu-
nity, health professionals involved in the delivery and up-
take of NHS Health Checks, and specific members of the
public who would benefit from a more targeted approach,
ensuring the best possible health outcomes.
Various stakeholder engagement approaches exist, in-
cluding questionnaires, interviews, focus groups, confer-
ences, forums and symposia, nominal group technique
and Delphi techniques [9, 11] The objective of these ap-
proaches also varies from canvassing and reflecting a
range of opinions, to building consensus or providing
expert opinion to fill gaps in the evidence. A review by
Mallery et al. [12] identified various innovative methods
including online, collaborative forums and online com-
munities. Stakeholder engagement ideally aims to estab-
lish and maintain involvement throughout the research
process and maintain interactivity between researchers
and users [13].
The level of stakeholder involvement employed can
vary depending upon the objectives of the engagement
and outcomes to be achieved [14]. The Organisation for
Economic Co-operation and Development [15] distin-
guishes six levels of stakeholder engagement depending
on the processes and the intentions they pursue. The
processes range from the least engaged to most engaged:
communication (sharing information to increase know-
ledge), consulation (gathering information and experi-
ence of stakeholders without obligation to use in fiinal
outputs), participation (taking part in the project
process, but not the decision making process), represen-
tation (structural level of engagement), partnerships
(agreed upon collaboration), co-production (balanced
share of power). Co-production was chosen for the
WorkHORSE project as it was imperative to deliver a
modelling tool that would be accessible, comprehensive,
and would ultimately lead to more effective NHS Health
Check uptake and delivery.
In its broadest sense, co-production is defined as a col-
laboration in governance, priority-setting, conducting re-
search, knowledge translation, which involves researchers
and others with a stake in the project [16]. In public health
research these can include public, patients, health care
providers, and decision makers and policy-makers. The
key component is joint decision-making [17]. In the con-
text of this study, joint decision-making referred to the
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research team and stakeholder participants, but did not
include patients. Co-production is regarded as a positive
component of research development and delivery. How-
ever, experts in the field have highlighted the potential
challenges and complexity of co-production. Doing co-
production properly can be expensive financially and in
terms of time. Coproduction as an aim of research needs
to consider the added value and usefulness in helping the
research meet its desired outcome. For example, ensuring
that the correct mix of stakeholders are involved, at the
appropriate stages of the research process, ensuring joint
decision making is managed and ensuring that coproduc-
tion supports, rather than mitigates against the quality of
the research [18].
Based upon the nature of the WorkHORSE project, to
develop a decision support tool for commissioners of the
NHS Health Check Programme (NHSHCP), we developed
a series of workshops utilising the co-production ap-
proach. WorkHORSE was a two-year project designed to
continuously engage with stakeholders, via four iterative
workshops, to coproduce an open-source/open-access
web-based modelling tool to enable commissioners to
quantify the potential cost-effectiveness and equity of the
NHS Health Check Programme in England. The NHSH
CP is offered at five-year intervals to all adults aged 40–
74 years who do not have pre-existing vascular conditions.
The programme aims to prevent cardiovascular disease
together with detecting diabetes and chronic kidney dis-
ease and raising awareness of dementia. The programme
includes cardiovascular disease (CVD) risk stratification
and people identified as being high-risk are offered appro-
priate treatment including behavioural change interven-
tions, statins for high cholesterol and antihypertensive
drugs for high blood pressure [19].
In our study, coproduction involved the research pro-
ject team (modellers, researchers and lay representatives)
and stakeholders (i.e. individuals involved in the assess-
ment, commissioning and delivery of NHS Health
Checks [19] (https://www.healthcheck.nhs.uk), a cardio-
vascular disease prevention programme delivered by
Local authorities). Through a series of four interrelated
workshops, a web-based decision support tool was devel-
oped via an interactive and iterative process whereby the
research team and stakeholders collaborated through all
phases of the research project.
The WorkHORSE project had five key aims: 1. Co-
produce proposals with stakeholders to inform the desir-
able features of the user-friendly model and identify add-
itional locally relevant scenarios to test. 2. Update the
evidence base to support model and scenario develop-
ment. 3. Further develop our computational model to
allow for developments and changes to NHS HCP and
the diseases it addresses. 4. Assess the effectiveness,
cost-effectiveness and equity of alternative strategies for
NHS HCP implementation. and 5. Propose a sustainabil-
ity and implementation plan to deploy our user-friendly
computational model at the local level.
The key objective was to evaluate the involvement of
stakeholders in co-producing the WorkHORSE com-
puter modelling tool and examine how they perceived
their involvement in the model building process and ul-
timately contributed to the strengthening and relevance
of the modelling tool.
In this paper, we describe the experience of the model-
lers, stakeholders and lay advisers in shaping and
informing the development of the model and the added
value of co-production.
Methods
Research participants
Stakeholder mapping and recruitment
We developed a stakeholder recruitment grid based on
our extensive public health networks at the local, re-
gional and national level. The WorkHORSE project team
identified relevant organisations, who were actively in-
volved in the commissioning/delivery of NHS Health
Checks and/or had a vested interest in development of
the modelling tool and the impact it would have on the
NHSHCP Individuals from these organisations were
added to the recruitment grid. The final recruitment grid
contained a diverse group of stakeholders from different
organisations including Public Health England (national
and regional level), British Heart Foundation, Diabetes
UK, Alzheimer’s UK, NICE (The National Institute for
Health and Care Excellence), BMA (British Medical As-
sociation), Alcohol Research UK, North West Strategic
Clinical Network, Director of Public Health, Local Gov-
ernment Association, Clinical Commissioning Groups
(CCGs), Local Authorities (LAs), GPs, Pharmacies and
Academics. Inviting a cross-section of stakeholders
representing local, regional and national perspectives
provided a broad skillset and perspective in the process
of co-producing the tool. Stakeholders were sent an
email invitation to attend the workshops. If specific
stakeholders were unable to attend, we used snowballing
techniques to identify other associated individuals at
their organisation to invite. Depending on the objectives
of the workshop, we would either deliberately have ta-
bles with a broad mixture of perspectives (HCP, local,
regional, national decision makers) or would sit people
from similar organisations on the same table.
Lay adviser recruitment and involvement
Four lay advisers were recruited via the National Insti-
tute for Health Research Patient and Public Involvement
Network and local Healthwatch. In the context of the
WorkHORSE project, the lay advisers were part of the
research team (i.e. Patient and Public Involvement in
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research, (PPI). Furthermore, they also provided us with
useful insights into their experience of being involved in
the co-production process. All the lay advisers had a
personal experience of using Health Checks and were in-
terested in how the development of the decision support
tool would benefit health check provision. The lay ad-
visers assisted the research team with the project appli-
cation, provided advice and support with the delivery of
the project, and ensured the perspective of the public
was represented by helping us to write clear, under-
standable literature for engagement with the public, and
dissemination within the research community from the
lay perspective.
The modelling team
It was imperative to evaluate the modelling team experi-
ence of the co-production process in order to provide
context to the stakeholders’ experience. The four com-
puter modellers were all team members of the NCD Pre-
vention and Food Policy Research Group, Department of
Public Health and Policy, University of Liverpool. All
had previous experience of developing computer deci-
sion support tools for end users.
Workshop design
The design of the workshop programme was theory-based
using the Cairney/Oliver key co-production principles [18,
20]. This included co-identifying the requirements of the
decision support tool based upon stakeholders’ current
views and experience and future requirements; to work it-
eratively over the lifespan of the project to co-steer the de-
cision support tool content and outputs, and to co-
develop interpretations of the decision support tool and
implications for dissemination and end-use.
These events were carefully planned using a “script ap-
proach”, an example is provided in Appendix 1, with the
scripted approach for Activity 1, Workshop 1 shown in
Table 1. We adapted previously validated scripts to our
specific needs and context in order to structure and gently
facilitate the worshop process (Scriptapedia based upon
the work of Hovmand et al. (2012) [21] group model
building (GMB) approach as part of a general framework.
GMB is a participatory method for involving people in de-
signing, creating or validating system dynamics models.
GMB consists of one or more sessions (workshops) with a
carefully selected group of stakeholders and the use of
small structured exercises with specific objectives and out-
puts; and the extensive use of facilitation, discussions and
analysis. These activities enabled the team to engage with
stakeholders in the co-design of the decision support tool,
facilitating open discussion and opportunities for stake-
holders to provide additional feedback subsequently.
The WorkHORSE project workshops had the overall
aim of co-producing the web-based decision support
tool with stakeholders. Each included a series of small-
group exercises with specific objectives and outputs. The
workshops were iterative in their approach and involved
an independent facilitator in their delivery. Each work-
shop used specific questions and activities. Immediate
feedback was obtained via Post-it Notes, flipcharts, small
group and plenary discussions (Table 2).
Evalaution and data collection
Both stakeholders and the modelling team completed
questionnaires with open-ended and closed questions to
evaluate the co-production process. At the end of each
workshop, stakeholders completed stakeholder engage-
ment questionnaires to explore their views and experi-
ences throughout the process. Questions included their
reasons for attending the workshops, their expectations
and what they gained from attending, and perceived added
value of their involvement. The modelling team also com-
pleted questionnaires to explore their expectations before
Table 1 Excerpt of scripted approach detailed in appendix 1
ACTIVITY 1 To identify stakeholder’s expectations of the WorkHORSE
health checks project; To identify what is working well and not so well and
future hopes for the NHS Health Checks Programme (NHS HCP)
Purpose: To elicit what is working well and not so well and future
hopes for the NHS HCP
Time: 25 min for the activity; 25 min feedback from individuals and
group discussion
Materials:
1. Flipchart paper with headings (what is working well, not so well and
future hopes) for each table of participants
2. Three different colours of post it notes for each participant
3. Back felt tip pens for each stakeholder
4. Masking tape
5. Tape recorder to record individual/group feedback/discussion
Outputs:
List of stakeholder’s comments regarding what is working well and not
so well and future hopes for NHS HCP.
Roles:
1. Facilitator with knowledge of the topic
2. Scribe/recorder to document the session
Steps:
1. Participants are given several sheets of paper in each colour. The
facilitator explains that they will be writing what they believe works well
and not so well and future hopes relating to NHS HCP and then sharing
them with the group.
2. The facilitator states which colour post it note represents working
well; not working well; future hopes, and to stick responses onto the
appropriate piece of flipchart paper (with headings)
3. Stakeholders have 25 min for the whole task (5 min to write down
individual thoughts, 20 min to discuss with other group members)
4. Each stakeholder reads out one aspect working well, one not so
well and future hope for NHS HCP. After each participant has shared
once, facilitator opens the floor to all participants for any further
comments about what is working well and not so well, challenges and
future hopes and opportunity for discussion. (25 min)
5. Facilitator then tries to identify some of the themes and summarises.
(10 min)
6. Scribe/recorder records all comments regarding what is working
well and not so well and future hopes in the session notes.
7. ALL flipchart paper to be collected from each table and either stuck
up at the back of the room or laid on tables at the back of the room –
stakeholders are encouraged to add additional comments at any time
to the flipchart papers.
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the workshops and their experiences thereafter. Questions
included the added value of having a series of workshops,
the process of co-production, how the decision support
tool benefited from stakeholder involvement. We continu-
ously evaluated our patient and public involvement with
our lay advisers throughout the project via meetings and
email in order to assess impact and to identify areas for
improvement in lay adviser involvement. At the end of the
project, the modelling team, stakeholders, and lay advisers
were emailed a final questionnaire, tailored accordingly, to
identify their overall experience of the project and co-
production process.
Thematic analysis
The qualitative information obtained from the question-
naires and notes from meetings with the lay advisers was
analysed using the principles of thematic analysis as de-
scribed by Braun and Clarke (2006) [22]. Familiarisation
of the data was carried out, reading through all of the
data and generating initial codes based upon the re-
sponses to the open questions. These were then grouped
into meaningful categories and further searched and
reviewed for themes. The responses were then cate-
gorised into a sufficiently small set of broad categories,
which were then coded and subsequently indexed.
Results
The series of four workshops were delivered at six
monthly intervals across two years (February 2018 to
October 2019). Thirty stakeholders participated in the
workshops, of which 15 attended two or more work-
shops. Stakeholders represented the local, regional and
national perspective, and included attendees from LAs,
CCGs, GPs, Academia, Public Health England and third
sector organisations (including NICE and British Heart
Foundation).
Developing a Foundation for Effective co-Production
Stakeholders rated workshop 1 at mean = 4.36, median =
4, range 3–5 (1 being poor, 5 being excellent).
Expectations of the co-production process
Most stakeholders indicated their anticipation at being
able to learn about the WorkHORSE tool, the research
process in tool development, and having the opportunity
to actively contribute. They also saw their knowledge,
expertise and user perspective as potentially contributing
to the components of the tool, to ensure that it was
user-friendly and relevant to the end-user. Many stake-
holders were enthused at the prospect of having a valu-
able tool which could lead to more effective and
equitable health checks delivery. Typical comments
included:
SH2–2 “To be included in creating a benefiting tool
for the NHS health check programme.”
SH12–2 “I think it is a potentially hugely valuable
tool that could help local areas design programmes
which would make them less resistant to universal
delivery.”
Some stakeholders commented how the process could
be improved: include more LA and CCG stakeholders as
they are key in making the decisions; have an example of
the impactNCD model [23] so stakeholders could place
what we mean by ‘model’; have more time as it was
Table 2 Summary of Workshop Aims and Activities
Workshop Aims Activity
1 • build a mutual working relationship between stakeholders
and the research team;
• ensure an understanding of the health checks process for
scenario building
• generate rich and valuable interaction to inform model
development
Activity 1: Groupwork to identify stakeholder’s expectations of the
WorkHORSE health checks project and identify what is working well and
not so well and future hopes for the NHS HCP (heterogeneous grouping)
Activity 2: Groupwork to elicit what features/specifications will make
WorkHORSE a useful tool for the stakeholders (homogenous grouping)
2 • develop the priorities for the model functionality
• explore how alternative implementations of health checks
could be modelled through the input parameters of the
tool
• clear specification on outputs/visualisations in terms of
immediate accessibility required by stakeholders
Activity 1: Groupwork to enable stakeholders to consider alternative HC
implementations and practice modelling these implementations leading to
a blueprint for co-produced scenario(s) (heterogeneous grouping)
Activity 2: Groupwork to rank the importance of model outputs and
visualisations which will make WorkHORSE a useful tool for stakeholders
(homogenous grouping)
3 • focus on the design and co-production of realistic model
scenarios (previously raised by stakeholders)
• explore model outputs and confirm their usefulness
Activity 1: Groupwork to enable stakeholders to discuss and co-produce
realistic model scenarios interpret model outputs and confirm their useful-
ness (heterogeneous grouping)
Activity 2: Groupwork to explore the importance of model outputs and
visualisations which will make WorkHORSE a useful tool for stakeholders
(heterogeneous grouping)
4 • dissemination and demonstration of the decision support
tool
Stakeholder demonstation of using the model and interpretation of
outputs (heterogeneous grouping)
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superficial to truly develop ideas synergistically, chal-
lenge them and the associated underlying assumptions
in the time allocated; have a sharepoint site to bring
tools and documents together; and a wider ‘virtual’
group to gain views electronically.
This was the first time the modelling team had engaged
with stakeholders regarding tool development. Prior to
Workshop 1, the team expectations of stakeholder’s con-
tribution were mixed. Responses indicated that while they
were hoping for some useful and innovative engagement,
their was unfamiliarity with the process of stakeholder en-
gagement and what could potentially be achieved.
M4. “I think that I was expecting them to provide
general ideas on scenario building features, but I
wasn’t really expecting them to understand model-
ling details at the required level. My expectations
were more about participation, being able to engage
them in a fruitful and useful discussion.”
Although initially there was apprehension about the
process of engaging with stakeholders, the team found
Workshop 1 exceeded their expectations and provided
added value to the tool development.
M2. “Yes, stakeholders were very engaged and came
up with lots of ideas. I was particularly pleased with
their enthusiasm and interest to participate.... I
think that as the first interaction with them, their
understanding was better than I thought, as exem-
plified by the suggestion of the Best Practices Tem-
plates Tool.”
The modelling team were able to reflect upon their
usual process and approach to model building. Usually,
decision support tools would be developed with little
consultation apart from internal colleagues, and the pos-
sibility of discussion with modelling peers.
M3. “The modelling team would have made all the
decisions without formal external input. After the
end of the project, the users, including current stake-
holders, would be able to provide feedback; but by
then we would have no resources and less flexibility
to react to their feedback.”
Co-production as a process for tool development
Stakeholders rated workshop 2 at mean = 4.5, median =
5, range 3–5 (1 being poor, 5 being excellent).
By Workshop 2, stakeholders expected the decision
support tool to have progressed as a result of their input
during Workshop 1. Stakeholders were eager to see a
prototype of the tool and how stakeholders were con-
tributing to the tool development.
SH4–2 “To see progress and how engagement with
stakeholders had contributed to that progress”.
SH9–2 “To see a prototype of the tool and how the
last workshop has shaped developments so far and
inform next steps”.
Stakeholders expressed greater insight and under-
standing of what the model would include and how it
would work. Furthermore, the opportunity to network
with other stakeholders provided the opportunity to gain
different perspectives regarding what to include in the
model, and how it would be used by various end-users.
SH3–2 “I was keen to see how the model had pro-
gressed and how it could be used to produce various
scenarios to potentially inform commissioning deci-
sions. It was also a great opportunity to network
with people from other areas and organisations”.
There was a consistent theme of co-production leading
to a tool that would be relevant to the end-user and
stakeholders being able to provide “real-world experi-
ence” related to actual work practices, range of different
perspectives and expectations of outputs.
SH12–2 “Massive value – it’s been fascinating to
watch academics extract from ‘real-world users’ the
information they need to make the tool truly ‘use-
able’. If the project is to have a tangible outcome
(the model tool) it will only be used if the end-users
have had an input and ensured it is relevant to
them”.
The perceived value of co-production in model devel-
opment was a continuous theme that became increas-
ingly highlighted by the stakeholders as the workshops
progressed, especially in ensuring relevance for end-
users.
SH1–3 “To continue supporting the development of
the tool and ensure it caters to the needs of localities
that are not pushing boundaries of health checks,
and to help ensure we end up with a product that’s
going to work on the ground.”
One participant commented that we needed to know
how those most “anti- “NHS Health Checks (i.e. senior
leaders not convinced about universal delivery) could
use the tool to inform approaches to delivery that would
work for their local populations.
Researcher feedback after the delivery of Workshop 2,
found the modelling team perceiving co-production as
providing validation for the decision support tool being
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developed and reassured that its development would be
of relevance to the end-user. Co-production ensured
that all aspects relevant to the end-user were being con-
sidered, not just what the development team thought
would be required.
By adopting this approach, the end-users would not
only have a decision support tool tailored to their needs
but would have an in-depth understanding of the
process involved in achieving the end product. Likewise,
the modelling team had a greater insight into why cer-
tain scenarios and outputs were necessary.
M1. “To make our research meaningful and helpful.
To help us on focusing on what is really important
for decision makers.”
M4. “First and foremost, transparency. Most model-
ling exercises are opaque.... Our approach put them
at the centre of the model, responding to their needs,
getting them engaged so that they help disseminate
the work once it is finished and be local champions
for it.”
The modelling team saw stakeholders as being able to
contribute not only to what was required for the deci-
sion support tool to be useful but also what should be
excluded, thus making the tool more refined and fit for
purpose. Specifically, they welcomed stakeholder contri-
butions in terms of the required inputs, outputs and the
graphic user interface.
M3. “I expect with their contributions to make the
GUI (Graphic User Interface) useful and more intui-
tive for the users. I also hope to identify which model
outputs are more useful to them so I can make them
more easily accessible in the GUI.”
Consolidation of the decision support tool via co-
production
Stakeholders rated workshop 3 at mean = 4.6, median =
5, range 4–5 (1 being poor, 5 being excellent) with all
participants stating the workshop achieved its objectives.
Many stakeholders attended Workshop 3 in order to
observe how the model had evolved from Workshop 2,
and understand how the model would work, especially
in terms of outputs.
SH3–3 “To further develop the tool in a positive, en-
ergetic, interactive workshop.”
SH11–3 “To see the next iteration of the tool. See
how learning from the previous workshop has been
used. Understand more about sustainability and fu-
ture plans for the tool.”
Stakeholders also commented upon the added value of
their involvement in the series of workshops. It provided
them with more confidence in the tool, as they had ob-
served and contributed to its development. Stakeholders’
comments indicated they felt the iterative workshop
process for model development was beneficial for both
them and the modelling team.
SH3–3 “Genuine proof these workshops and communica-
tions- in- between have impact – mixed model and func-
tionality now built in, which is marvellous. A better
understanding of reality of delivery for those on the
ground.”
SH5–3 “Awareness that previous comments have
been taken into account, and valuable insight and
understanding of the tool, its benefits and
capabilities.”
All stakeholders were very positive regarding the ad-
vantage of having a series of workshops as opposed to
one workshop. Most importantly, they saw it as an op-
portunity to learn about and reflect upon the tool’s cap-
acity, usage and usefulness as an end product.
SH2–3 “Huge! It would be too much to take on over
one day. Division months between workshops provided
the opportunity to reflect and think of questions.”
SH8–3 “You end up with something truly copro-
duced, doing what people need it too. I worry this is
not the case with other things we’ve commissioned
development of recently.”
SH10–3 “Greater clarity and more sophisticated un-
derstanding of subsequent iterations of the model.
The group was more aware of the detailed issues
having attended previous workshops. More informed
and detailed discussions.”
Some stakeholders commented how the process could be
improved: to practice more scenarios; to allow more time for
discussion; and increase representation from LAs and CCGs.
The third Workshop was a culmination of the co-
production process. The modelling team felt it provided
an opportunity to refine the decision support tool,
achieve consensus and have endorsement of the tool that
had been created through the series of workshops.
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M2. “Keep participants on board with the co-
production process. Getting feedback before the inter-
face is completed.”
M3. “Reassurance that we are travelling to the right
direction. At that stage of the project there was still
time to improve the fundamentals if necessary.”
M4. “Because of the success of the experience, we
gained valuable feedback re the user experience with
the model, good discussions regarding the complexity
and usefulness of the model, and very useful conver-
sations on how the real LA setting in terms of ana-
lytical and modelling skills set can be enhanced by
the model interface. This will be invaluable for the
final design of the user interface.”
Furthermore, it was felt the stakeholders added dimen-
sions to the tool that would not have been identified by
the modelling team alone.
M3 “There were many small additional improve-
ments. Most of them very smart and useful that I
would have never thought by myself.”
M4 “. … particularly in how to help the user through
the interface to understand some of the concepts and
outputs of the model.”
Having co-produced the model with stakeholders, the
modelling team increased confidence in the decision
support tool that its was being built. They have reassur-
ance and endorsement from end-users that what has
been created will be “fit for purpose”.
M2 “I am really pleased with how the model is look-
ing. It is better than I thought it would be.”
M3 “I am now confident that the WorkHORSE
model may fulfil its purpose to be useful and support
policy makers to make better decisions …”.
M4 “I am extremely pleased in viewing in action
the principle of co-production. Features suggested
in WS2 and implemented and demonstrated in
WS3, providing an opportunity to iterate and
incrementally improve the usefulness of the
model.”
Demonstrating proof of concept
Stakeholders rated workshop 4 at mean = 4.4, median =
4, range = 4–5 (1 being poor, 5 being excellent).
Stakeholders attended the final workshop in order to
support the development of the model and to contribute
to its final iteration.
SH 4–4 “To complete the participation in this
programme and activity”.
SH 8–4 “To contribute to stakeholder discussions
supporting the development process of this
model”.
Stakeholders appreciated the opportunity to observe
and discuss the tool with other stakeholders from differ-
ent organisations and localities. They commented on the
progression of the model and welcomed the opportunity
to observe the final version and how it could be used in
practice.
SH 1–4 “Really great understanding around the
tool/data/the art of the possible”.
SH 4–4 “Better understanding of how the model will
support me around future decisions for health
checks”.
SH 8–4 “Having different perspectives and needs
from other stakeholders, seeing the progress and
development of this model. Learning the capability
of the new tool and how it can be applied”.
Stakeholders expressed satisfaction with the decision
support tool presented to them. They were enthused at
the prospect of having a tool that would provide them
with various scenarios and being able to demonstrate
the capabilities of the NHS Health Checks programme
at various levels.
SH2–4 “Opportunity to use the model to show im-
pact of various scenarios which wasn’t available
before”.
SH4–4 “Being able to demonstrate HC effectiveness/
HC programme evolving/cost effectiveness of HC is
still possible”.
SH8–4 “The new tool that will be publicly avail-
able will provide valuable information of the NHS
Health Check at both national and local levels. It
is also brilliantly flexible for all types of users in
planning, managing and monitoring their local
provision”.
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The modelling team valued the opportunity to demon-
strate to stakeholders, and for stakeholders to demon-
strate to their peers, how the decision support tool had
been directly informed by the co-production process.
Thus, resulting in a product that would be user-friendly.
M2 “Show the tool and how we have responded to
stakeholder input into the project”.
M3 “To allow the stakeholders demonstrate the use
a working version of the model and to get final com-
ments and suggestions from them”.
Expectations were met in terms of the “lively and in-
teresting conversations”(M1) held between stakeholders
and stakeholders and the team. Having workshop 4 en-
abled the modellers to demonstrate “proof of concept”
(M1) and being able to “debrief stakeholders” (M2). M3
commented upon how one of the stakeholders tool dem-
onstrations provided new ways of thinking for the mod-
ellers: “… they used the model in a way I haven’t
previously thought of. I found this exciting”.
The process of co-production was deemed a success
by the modelling team, with the right mix of stake-
holders participating and their views incorporated into
tool devleopment. Although one modeller commented,
input from practice nurses may have been useful (M2).
Also, M1 commented: “… Of course there is much more
to do, as key aspects to be contemplated in the Imple-
mentation plan might benefit from more interactions, but
sadly we are not funded to do that work.” This comment
was reiterated in relation to changes they would have
made to the process of co-production.
Moving forward, all the modelling team felt that model
development was only one component of enabling stake-
holders to use the tool to inform decisions. Stakeholders
would require training and support to ensure successful
implementation in the workplace.
M1 “Develop their own use cases and modify edit
the tool for that purpose We build the tool with that
flexibility, so it will be the ultimate proof of concept.”
M2 “Some funding for training and ongoing
support”.
M3 “We produced a prototype. Now we need the
production pipeline and the training”.
Lay advisers feedback
The lay advisers felt valued in their involvement in the
project. They perceived their role as acting as public
consultants and translators of information for a wider
audience and as advocates adding value from the public
perspective and observing the “return on investment” for
the public funding provided to the project via the re-
search body.
Their involvement in the writing of the research pro-
posal was highlighted as a positive approach to co-
producing with the public:
LA 1 “… beginning was excellent in terms of involve-
ment. I loved commenting on the bid. The first meet-
ing was taking our views and making a key
contribution to how the bid would look … although
it felt a bit over my head, we thought it was looking
at Health Checks, not specifically modelling. It took
time to figure out the idea of modelling … .but I did
enjoy it.”
However, as illustrated by the comment above, the lay
advisers felt their involvement was inhibited by the na-
ture of the project. They commented that LA 2 “the pro-
ject was quantitative and we look more into the
qualitative … PPI is important because it influences the
care standard of what the patient is receiving.”
Conversley, they did identify their valuable role in dis-
semination, in order to ensure that the research findings
reached the public realm, including co-producing sum-
maries of the research for publication in, for example,
local government newsletters.
Discussion
Summary of main findings
We believe this to be an innovative project in the field
of developing a decision support tool using the princi-
ples of co-production and evaluating the experiences
and reflections of those involved in the process. Studies
have reported upon co-production as a method of in-
creasing user involvement, primarily in the form of ex-
ploratory studies [24, 25] or case study [26–31] reviews.
However, there is a dearth of literature relating to the
combined experience of a team of modelling researchers
and stakeholders on iteratively co-producing a simula-
tion decision support tool.
Stakeholders experiences were positive overall. They
felt valued and commended the involvement of practi-
tioners. Major reasons for particpation included being
able to influence the development of the tool and gain-
ing insight and understanding of what the tool could in-
clude and how it would work in practice. They
appreciated the iterative process involving a series of
workshops which provided opportunities for them to
learn about and reflect upon the model’s capacity, usage
and usefulness. We have previously reported on the en-
gagement with the stakeholders in workshop 1, where
we aimed to explore the NHSHCP in terms of what is
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working well, less well and future hopes, and explore
features to potentially include in a useful decision-
support tool for stakeholders. The stakeholders demon-
strated their commitment to NHSHCP whilst highlight-
ing the perceived requirements for enhancing the service
and discussing how the decision-making tool would be
instrumental in this process. Their suggestions for im-
provement informed subsequent WorkHORSE work-
shops and model development [32].
The modelling team saw the process as an opportunity
for developing a common language and trust in the end
product and ensuring the support tool was transparent.
The workshops acted as a reality check, ensuring model
scenarios and outputs are relevant and fit for purpose.
This was the first time that our research team had in-
volved lay advisers in a research project involving the de-
velopment of a modelling tool. As a team we learnt the
added value of having a lay perspective on the project be-
ing delivered and consideration of how we can improve
our lay involvement in the process of co-production. Fu-
ture projects could be enhanced by having PPI input at
the research proposal development stage, together with a
strategy outlining definitive roles for the project duration.
There is a need to be aware that lay advisers are members
of the public and the academic environment can be ini-
tially daunting. Time is required to establish relationships
and to enable lay advisers to familiarise themselves with
the academic environment as well as the project itself.
Linking to prior studies
Jun et al. (2011) reported a similar methodology for the
development of a modelling simulation tool for health
care management. Albeit they did not evaluate the en-
gagement process, they believed such an approach would
enable health care modelling consultants and researchers
to collaboratively inform future models to meet the di-
verse needs of various health care clients [33]. Key fea-
tures of the WorkHORSE co-production process were:
a) having on-going dialogue between the modelling team
and stakeholder participants and b) ensuring stakeholder
feedback was an integral part of the decision support
tool development, thereby ensuring the final tool would
be valid and relevant for the NHS HCP. This is sup-
ported by Tabriz et al. (2019) [31], who describe the de-
velopment of a logic model framework for a healthcare
organisation–university-based research partnership for
delivery system sciences. Key elements to success in-
cluded pragmatic and responsive researchers and
knowledgeable stakeholders; having shared learning and
problem-solving opportunities; and transparent and joint
decision-making.
The basic requirements to co-produce in research is the
willingness and capacity of the participants to be involved,
and for the researchers to appreciate the participants’
contributions [34]. Writers have previously commented
that co-production in research “interferes” with conven-
tional practices of researchers [13]. This is a major issue in
the development of dynamic simulation tools, where re-
searchers rarely consult with the end-user. Including par-
ticipants with no research background in the decision-
making requires major changes in the researcher’s role
and the power-relationship between them and the partici-
pants (Pohl et al., 2010) [17]. In this study, the stake-
holders demonstrated a commitment to developing a
decision support tool which would benefit the delivery of
the NHS HCP. The modelling team had no previous ex-
perience of engaging with stakeholders in developing a de-
cision support tool and there was initially some
uncertainty about the added value of involving stake-
holders. However, it soon became apparent the benefit of
stakeholder involvement and the team embraced the
process of co-production.
Oliver [18] highlights the various costs of co-
producing research with stakeholders. These include the
practical costs (e.g. arranging venue, travel, researcher
time and resources), personal costs to researchers (e.g.
increased interpersonal conflict), costs to research (e.g.
time and effort to manage relationships), costs to stake-
holders (e.g. time away from their day job). Our experi-
ence endorses many of these. The series of workshops
entailed a substantial amount of preparation, planning
and choreographed delivery, with regular team meetings.
Also, we needed to ensure the location was accessible to
stakeholders and have the technology for demonstrating
and developing the tool. Recruitment of the stakeholders
was only the beginning of the process, maintaining and
building upon initial interest and commitment took time
and required an understanding of their profession, what
they brought to the workshops, and what they wanted
from the decision support tool. As a research team, we
were also conscious of the added pressures upon the
modellers to build the decision support tool based upon
the iterative process. It was a change to the traditional
approach of no or limited consultation, resulting in add-
itional time required. From our experience, we encour-
age the use of co-production. However, co-production
should not be taken on lightly, serious consideration
should be given to the added benefit for the outcome of
the research by co-producing. There needs to be a sup-
portive and constructive team, with defined yet collab-
orative roles. Substantial time and commitment need to
be allocated to the process. There also needs to be clear
aims and objectives and outcomes for the workshops
themselves and the overall project.
Strengths and limitations
The strengths of this study are the use of a systematic
and transparent process [20] to coproduce the priorities
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for the decision support tool. The series of four iterative
workshops provided an ideal opportunity to engage with
a broad range of stakeholders. There was opportunity
for individual opinions to be expressed via writing down
views before group discussion while engaging in group
work activities encouraged group consensus. The in-
volvement of lay members of the public also contributed
to decisions about project development, delivery and
dissemination.
There are limitations. Firstly, although stakeholders
from a variety of organisations and backgrounds
attended, most of the stakeholders were unable to attend
all four of the workshops leading to potential bias. For
example, some stakeholders only attended Workshop 1
and 3. However, this was addressed by providing a
“catch up” session immediately prior to the main work-
shop for previous non attendees. We had a good repre-
sentation of stakeholders from all levels (national,
regional and local) and are confident we captured a
cross-section of views. Secondly, although stakeholders
represented a cross-section of local and national organi-
sations, participants were not always represented by the
end-user of the decision support tool. Future studies
should include more end-users who may use decision
tools (e.g. public health analysts). Furthermore, stake-
holder feedback was predominantly supportive, suggest-
ing participants may have been bias to those who were
eager for a modelling tool to be successfully developed
and implemented to support the commissioning of the
NHS HCP. Future projects should ensure a more diverse
group of stakeholders (e.g. sceptical of the use of model-
ling tools for NHS HCP delivery). Thirdly, lay members
overall felt valued in being involved in the project how-
ever the nature of the project (development of a com-
puter decision support tool) at times meant that lay
members did not feel able to fully contribute to the co-
production process. This might require further thinking
on how to effectively involved lay perspectives in model-
ling when the public is not the intended end-user. Fu-
ture projects need to ensure that lay members are better
informed about the nature of the research and feel
confident in their ability to contribute.
Conclusions
The WorkHORSE dynamic simulation tool was devel-
oped to provide decision-makers and practitioners with
a web-based decision-support tool to help identify the
most effective, cost-effective and equitable interventions
for the NHSHCP. Computational modellers rarely con-
sult with end-users when developing tools to inform
decision-making. The added value of involving stake-
holders in the co-production of tool development en-
abled productive and valuable dialogue, provided
valuable learning about potential problems in practice,
and supported consensus building for effective end-use.
The resulting level of engagement resulted in modellers
producing a “real-world” operational tool, with the cap-
acity to test a large range of scenarios to determine their
likely short-term and longer-term impacts. Likewise,
stakeholders have increased confidence in the decision
support tool’s development and applicability in practice,
with a robust basis for decisions on the delivery of the
NHSHCP.
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